Michael Rogers, the FDA's associate commissioner for inspections and investigations, announced his resignation after over three decades with the agency. His tenure had been marked by significant challenges, including overseeing the agency during the 2022 infant formula crisis and a subsequent reorganization of the inspections office in 2024. Frustration among inspectors has reportedly been growing due to staffing cuts initiated by Secretary Robert F. Kennedy Jr. Meanwhile, FDA Commissioner Dr. Marty Makary announced plans to reduce the duration of foreign inspections, raising concerns about the feasibility of maintaining effective oversight with diminished resources.
Rogers' departure marks the culmination of a challenging tenure at the FDA as inspectors expressed frustration over agency leadership amid significant staff cuts.
Rogers stated, 'I have decided to retire. It was my decision, but it was time after 34 years,' suggesting a voluntary departure after a long career.
Despite public claims of expanding inspections, internal frustrations at the FDA highlight the ongoing struggles with staffing and operational issues.
FDA Commissioner Dr. Marty Makary indicated plans to shorten foreign inspection lengths, asserting this would enable more inspections despite reducing personnel.
Collection
[
|
...
]